Volpara Health Technologies רווח לפני ריבית ומס (EBIT) 2024

מה עושה Volpara Health Technologies?

Volpara Health Technologies Ltd is a medical technology company that specializes in offering products and services for breast cancer diagnosis and treatment. The company was founded in 2009 in New Zealand and has its headquarters in Wellington, as well as branches in the US, UK, and Australia. The business model of Volpara revolves around providing a cloud-based software platform called VolparaEnterprise, specifically developed for breast cancer diagnosis and treatment. This platform offers radiologists and radiological screening centers a complete range of tools to assess risks, make diagnoses, and plan treatments. It integrates automatic image analysis, artificial intelligence, and machine learning to enable more accurate and faster screenings. Volpara also assists in the interpretation of mammography images, particularly in assessing breast density, which is an important risk factor for the development of breast cancer. The company has developed a range of products, including VolparaDensity, VolparaLive! (formerly MRS), VolparaScore, and VolparaHealthchecks. Volpara has several divisions focusing on different aspects of breast cancer diagnosis and treatment: 1. VolparaClinical: This division is responsible for developing products for breast cancer diagnosis and assessment. These products include automated image analysis software and services for radiologists. 2. VolparaResearch: This division conducts clinical studies and research activities to expand knowledge and understanding of breast cancer. 3. VolparaEnterprise: This division offers a cloud-based software platform for radiological screening centers. The platform enables monitoring of image quality, risk assessment, disaster management, and continuing education for image screeners. 4. Volpara Solutions: This division is responsible for developing solutions for clinical decision support and patient management. The products offered by Volpara include VolparaDensity, an automated software for assessing women's breast density, VolparaLive!, an image analysis software for real-time monitoring of mammography image quality, VolparaScore, an automated software for assessing women's breast cancer risk, and VolparaHealthchecks, a set of tools for monitoring and treating breast cancer patients and assessing the risk for women with higher breast density. In conclusion, Volpara Health Technologies Ltd is a leading company in breast cancer diagnosis and treatment. The company aims to improve the efficiency and accuracy of mammography screenings and precise diagnosis of breast cancer. With a wide range of products and services, Volpara Health Technologies Ltd is on the right path to saving lives and winning the battle against breast cancer. Volpara Health Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.